A study by Friends of Cancer Research found that prescription drug labels often did not list the uses of cancer drugs recommended by oncologists, suggesting patients may not receive the most current care if physicians rely only on labeling to inform their prescription choices. Rheumatology drugs have a similar labeling problem, according to the American College of Rheumatology.
Outmoded drug labels can hinder treatment options
Sign up for SNMMI SmartBrief
Nuclear medicine and molecular imaging news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.